Loretta Nastoupil^1*, Saurabh Dahiya, MD, FACP^2*, Maria Lia Palomba, MD³, Alejandro Martín García-Sancho^4*, Juan Luis Reguera, MD^5*, John Kuruvilla, MD, FRCPC⁶, Ulrich Jaeger, MD⁷, Guillaume Cartron, MD, PhD^8*, Koji Izutsu, MD, PhD⁹, Martin Dreyling, MD¹⁰, Brad S. Kahl, MD¹¹, Herve Ghesquieres, MD, PhD^12*, Kirit Ardeshna, MD, MA, FRCP^13*, Hideki Goto, MD, PhD^14*, Anna Maria Barbui, MD^15*, Jeremy S. Abramson, MD¹⁶, Peter Borchmann, MD¹⁷, Isabelle Fleury, MD, MSc¹⁸, Stephan Mielke, MD¹⁹, Alan P Skarbnik, MD²⁰, Manali Kamdar, MD, MBBS^21*, Reem Karmali, MD²², Andreas Viardot, MD, PhD²³, Thalia Farazi, MD, PhD²⁴, Grace Shih Hui Kao, MD²⁵, Min Vedal, PhD^26*, Rina Nishii, PhD^27*, Jessica Papuga, PhD^26*, Jinender Kumar, MS^27* and Franck Morschhauser, MD, PhD²⁸

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain
⁵Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Seville, Spain
⁶Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Medical University of Vienna, Vienna, Austria
⁸Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France
⁹National Cancer Center Hospital, Tokyo, Japan
¹⁰Medizinische Klinik III, Klinikum der Universität, LMU München, München, Germany
¹¹Washington University School of Medicine in St. Louis, St. Louis, MO
¹²Hôpital Lyon Sud, Lyon, France
¹³University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹⁴Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
¹⁵Azienda Socio Sanitaria Terriroriale Papa Giovanni XXIII, Bergamo, Italy
¹⁶Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
¹⁷Universität zu Köln, Köln, Germany
¹⁸Hôpital Maisonneuve – Rosemont, Montreal, ON, Canada
¹⁹Karolinska Institutet and University Hospital; Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden
²⁰Novant Health Cancer Institute, Charlotte, NC
²¹University of Colorado Cancer Center, Aurora, CO
²²Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
²³University Hospital, Ulm, Germany
²⁴Bristol Myers Squibb, San Francisco, CA
²⁵Bristol Myers Squibb, Cambridge, MA
²⁶Bristol Myers Squibb, Boudry, Switzerland
²⁷Bristol Myers Squibb, Princeton, NJ
²⁸Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France

Michael Wang, MD¹, Andre Goy, MD, MS², Javier Munoz, MD^3,4*, Frederick L. Locke, MD⁵, Caron A. Jacobson, MD, MMSc⁶, Brian T. Hill, MD⁷, John Timmerman, MD⁸, Ian W. Flinn, MD, PhD⁹, David B. Miklos, MD, PhD¹⁰, John M. Pagel, MD, Ph.D, DSc¹¹, Marie José Kersten, MD, PhD^12*, Edouard Forcade, MD, PhD^13*, Max S. Topp^14*, Roch Houot, MD, PhD^15*, Amer Beitinjaneh, MD^16*, Dan Zheng, PhD^17*, Mengru Chang, MSc^17*, Rhine Shen, PhD^17*, Wangshu Zhang, PhD^17*, Rita Damico Khalid, DO^17*, Ioana Kloos, MD, FRCPC^17* and Patrick M. Reagan, MD¹⁸

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²John Theurer Cancer Center, Hackensack, NJ
³Mayo Clinic, Phoenix, AZ
⁴Banner MD Anderson Cancer Center, Gilbert, AZ
⁵Moffit Cancer Center, Tampa, FL
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Cleveland Clinic Foundation, Cleveland, OH
⁸UCLA David Geffen School of Medicine, Los Angeles, CA
⁹Tennessee Oncology & OneOncology, Nashville, TN
¹⁰Stanford University, Stanford, CA
¹¹Swedish Cancer Institute, Seattle, WA
¹²Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹³Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
¹⁴Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
¹⁵CHU Rennes, Univ Rennes, Inserm & EFS, Rennes, France
¹⁶University of Miami, Miami, FL
¹⁷Kite, a Gilead Company, Santa Monica, CA
¹⁸University of Rochester School of Medicine, Rochester, NY

Manasawee Tanariyakul^1*, Sakditad Saowapa, MD², Akihiro Miyashita, MD^1*, Chalothorn Wannaphut, MD¹, Panisara Fangsaard, MD^3* and Kensuke Takaoka, M.D., MSc, PhD^1*

¹Department of Internal Medicine, University of Hawaii John A.Burns School of Medicine, Honolulu, HI
²Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX
³Department of Internal Medicine, Bassett Medical Center, Cooperstown, NY

Irene Dogliotti, MD^1*, Cristina Jimenez, PhD^2*, Veronica Peri^3*, Martina Ferrante, PhD^4*, Davide Musto^5*, Silvio Mercadante, PhD^5*, Gian Maria Zaccaria, PhD^6*, Marco Ghislieri, PhD^7*, Giulia Benevolo, MD^4*, Enrique M. Ocio⁸, Araceli Rubio, MD^9*, Ilda Maria Murillo, MD^9*, Fernando Escalante^10*, Carmen Aguilera, MD^11*, Aránzazu García Mateo, PhD^12*, Alfonso Garcia de Coca^13*, Roberto Hernandez^14*, Julio Dávila-Valls^15*, Federica Cavallo^3*, Noemi Puig, PhD¹⁶, Almudena Navarro Bailon, MD^17*, Veronica Gonzalez-Calle, MD, PhD^18*, Maria Eugenia Sarasquete, PhD^18*, Miguel Alcoceba, PhD^19*, Simone Ragaini^4*, Michele Clerico^4*, Chiara Consoli, MD^3*, Maria Garcia Alvarez, PhD^18*, Carmen Chillon, MD^18*, Alejandro Medina, PhD^18*, Marcos Gonzalez Diaz, MD^18*, Norma C. Gutierrez^20*, Benedetto Bruno, MD, PhD⁴, Daniela Drandi^4*, Simone Ferrero, MD²¹ and Ramon García-Sanz, MD, PhD¹⁸

¹Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
²Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, ESP
³Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
⁴Division of Hematology 1, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁵Division of Hematology 1, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
⁶Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari, Italy
⁷Department of Electronics and Telecommunications, Politecnico di Torino, Turin, 10129, Italy and PolitoBIOMed Lab, Politecnico di Torino, Torino, Italy
⁸Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain
⁹Hematology Department, Hospital Miguel Servet, Zaragoza, Spain
¹⁰Hospital Universitario de Leon, Leon, Spain
¹¹Hematology Department, Regional Hospital of El Bierzo, Leon, Spain
¹²Department of Hematology, Hospital General de Segovia, Segovia, Spain
¹³Department of Hematology, Clinical Hospital of Valladolid, Valladolid, Spain
¹⁴Hematology Department, Hospital Virgen de la Concha, Zamora, Spain
¹⁵Hospital Universitario Nuestra Senora de Sonsoles, Avila, ESP
¹⁶Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
¹⁷Hospital Universitario de Salamanca, Salamanca, Spain
¹⁸Haematology Department, University Hospital of Salamanca, Research Biomedical Institute of Salamanca (IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain
¹⁹Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Center of Salamanca-IBMCC (USAL-CSIC), Salamanca, Spain
²⁰Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
²¹Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy

Guifang Ouyang^1*, Lixia Sheng^1*, Jiaping Wang^1*, Hui Zeng^2*, Shanhao Tang^1*, Xibin Xiao^3*, Yamin Tan^4*, Qunyi Guo^5*, Yanping Shao^5*, Minchao Yan^2* and Wenbin Qian³

¹Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
²Department of Hematology, the First Affiliated Hospital of Jiaxing University, Jiaxing, China
³Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
⁴Zhejiang Cancer Hospital, Hangzhou, China
⁵Department of Hematology,Taizhou Hospital Of Zhejiang Province, Taizhou, China

Muhammad Junaid Tariq, MBBS¹, Kristopher Attwood, PhD, MS^2*, Andrea Carolina Anampa-Guzmán, MD^1*, Showkat Hamid, MD¹, Alex Niu, MD^3*, David Kaldas, MD⁴, Shrinjaya B Thapa, MD⁵, Jessica Leng^6*, Youssef Youssef, MD⁷, Keegan Carroll^8*, Rachel Treitman, BS^9*, Abdul Rafae, MD, MBBS¹⁰, Sachi Singhal, MD, MBBS^11*, Shazia K. Nakhoda, MD^12*, Samer Al Hadidi, MD, MSc¹⁰, Steven M. Bair, MD¹³, Timothy Voorhees, MD, MSc¹⁴, Narendranath Epperla, MD, MS¹⁵, Paolo F. Caimi¹⁶, Ariel F. Grajales-Cruz, MD¹⁷, Francisco Hernandez-Ilizaliturri, MD¹⁸ and Matthew J Cortese, MD, MPH¹⁹

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Medicine (Lymphoma Section), Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Moffitt Cancer Center, Tampa, FL
⁵H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁶School of Medicine, Case Western Reserve University, Cleveland, OH
⁷The Ohio State University, Columbus, OH
⁸Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁹University of Colorado School of Medicine, Denver, CO
¹⁰University of Arkansas for Medical Sciences, Little Rock, AR
¹¹Hematology/Oncology, Temple University/Fox Chase Cancer Center, Upland, PA
¹²Fox Chase Cancer Center, Philadelphia, PA
¹³Division of Hematology, University of Colorado - Anschutz, Denver, CO
¹⁴Division of Hematology, The Ohio State University, Columbus, OH
¹⁵James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹⁶Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁷H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁸Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY
¹⁹Roswell Park Comprehensive Cancer Center, Department of Medicine (Lymphoma Section), Buffalo, NY

Zachary D. Epstein-Peterson, MD^1,2, Christine E. Ryan, MD³, Sean M. Devlin, PhD^4*, Noa Golan Accav^5*, Abraham Avigdor, MD⁶, Magdalena Corona, MD, PhD^7*, Ivetta Danylesko, MD^8*, Jamie Dela Cruz^9*, Andre Goy, MD, MS^10,11, Caron A. Jacobson, MD, MMSc³, Ofrat Beyar Katz¹², Hazim Khatib, MD^12*, Anita Kumar, MD¹³, Lori A. Leslie, MD¹⁴, Alejandro Luna, MD, PhD^15*, Ronit Marcus, MD^16*, Reid W. Merryman, MD¹⁷, Miguel Angel Perales, MD^18,19, Alfredo Rivas-Delgado, MD, PhD², Gilles Salles, MD, PhD^1,20, Michael Scordo, MD^1,21, Inbal Sdayoor, BSc^22*, Gunjan L. Shah, MD^1,23, Noga Shem-Tov, MD^22*, Avichai Shimoni, MD^24*, Nataly Vahaba^12*, Ronit Yerushalmi, MD²², Andrew D. Zelenetz, MD, PhD², Maria Lia Palomba, MD^2,18, Andrew Ip, MD, MSc¹⁰ and Roni Shouval, MD, PhD^7,25

¹Department of Medicine, Weill Cornell Medical College, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel
⁶Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
⁷Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Ramat Gan, Israel
⁹Dana Farber Cancer Institute, Boston, MA
¹⁰Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
¹¹John Theurer Cancer Center, Hackensack, NJ
¹²Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
¹³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
¹⁴Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
¹⁵Unidad de trasplante y terapia celular, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹⁶School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel Aviv, Israel
¹⁷Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹⁸Department of Medicine, Weill Cornell Medical College, New York
¹⁹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²⁰Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
²¹Transplant and Cellular Therapy Services, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, NY
²²Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
²³Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
²⁴Division of Hematology and Bone Marrow Transplantation Department, Chaim Sheba Medical Center, Tel-Aviv, Israel
²⁵Department of Medicine, Weill Cornell Medicine, New York, NY

Alexander Grunenberg, MD^1*, Birgit Schmelze^2*, Jaqueline Gökeler^3*, Heike Mund^2*, Andreas Viardot, MD, PhD¹, Jens Dreyhaupt^4*, Gabriele Nagel^5*, Marcel Reiser, MD^6*, Thomas Gabrysiak^7*, Friederike Braulke^8*, Juergen Dunst^9*, Rudolf Schlag, MD^10*, Tobias Gaska, MD¹¹, Volker Runde^12*, Doris Kramer^13*, Thomas Weber^14*, Lothar Müller, MD^15*, Patricia Johansson, MD^16*, Carsten Ziske^17*, Georg Hess, MD^18* and Christian Buske, MD²

¹Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
³University Hospital Ulm, Ulm, Germany
⁴Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
⁵University of Ulm, Ulm, Germany
⁶Praxis für internistische Onkologie und Hämatologie (PIOH), Frechen, Germany
⁷Onkologisches Zentrum, Wolfsburg-Helmstedt, Germany, Wolfsburg, Germany
⁸University Medical Center Goettingen, Goettingen, DEU
⁹Department of Radiotherapy, University Hospital Kiel, Kiel, Germany
¹⁰Practice for Hematology and Oncology Wuerzburg, Wuerzburg, Germany
¹¹Brüderkrankenhaus St. Josef, Paderborn, Germany
¹²Wilhelm-anton-Hospital, Goch, Germany
¹³Kath. Krankenhaus Hagen gem. GmbH, St.-Josefs-Hospital Hagen, Hagen, Germany
¹⁴Department of Internal Medicine IV, Haematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany
¹⁵Praxis Leer, Onkologie UnterEms, Leer, Leer, Germany
¹⁶Department of Haematology, University Hospital Essen, Essen, Germany
¹⁷St. Josef-Hospital Troisdorf, Practice Network Hematology and Intern. Oncology, Troisdorf,, Troisdorf, Germany
¹⁸University Clinic Mainz, Mainz, Germany

Jose C. Villasboas Bisneto, MD¹, Stephen D. Smith, MD², Danielle S Wallace, MD³, Jean Pierre Marolleau, MD⁴, Carlos Grande Garcia, MD PhD^5*, Reid W. Merryman, MD⁶, Francesc Bosch, MD, PhD⁷, Luca Arcaini, MD^8*, Antonio Pinto^9*, Norma C. Gutierrez^10*, Brian G. Till, MD¹¹, Pierre Morel, MD, PhD^4*, Rocío Figueroa Mora, MD, PhD^5*, Cristina García, MD^7*, Sara Rattotti, MD^8*, Lucie Aubergeon, PhD^12*, Laurent Chêne, PhD^12*, Jan Fagerberg, MD, PhD¹², Pier Luigi Zinzani, MD, PhD¹³, Philippe Armand, MD, PhD⁶, Jonathan W. Friedberg, MD¹⁴ and Stephen M. Ansell, MD, PhD¹

¹Mayo Clinic, Rochester, MN
²Fred Hutchinson Cancer Center, Seattle, WA
³Wilmot Cancer Institute, University of Rochester, Rochester, NY
⁴Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
⁵Universidad de Navarra, Pamplona, Spain
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷University Hospital Vall d’Hebron, Barcelona, Spain
⁸Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
⁹Fondazione 'G. Pascale', IRCCS, Naples, Italy
¹⁰Hospital Universitario De Salamanca, IBSAL, Salamanca, Spain
¹¹Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
¹²Enterome, Paris, France
¹³University of Bologna, Bologna, Italy
¹⁴University of Rochester, Rochester, NY

Neha Akkad, MD¹, Amy Ayers, MPH^2*, Kumudha Balakrishnan, MPhil, MSc, PhD^2*, Loretta Nastoupil^2*, Dai Chihara, MD, PhD², Luis Malpica, MD^2*, Paolo Strati, MD², Ziyi Li, PhD^3* and Christopher R. Flowers, MD, MS²

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TT
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

Maria Gavriatopoulou^*, Ioannis Ntanasis-Stathopoulos, MD, PhD, MSc^*, Vasiliki Spiliopoulou, MD^*, Charalampos Filippatos^*, Magdalini Migkou, MD^*, Panagiotis Malandrakis, MD^*, Foteini Theodorakakou, MD^*, Nikolaos Kanellias^*, Evangelos Eleutherakis-Papaiakovou, MD^*, Despina Fotiou, MD^*, Evangelos Terpos, MD, PhD, Meletios-Athanasios Dimopoulos and Efstathios Kastritis, MD, PhD^*

Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Daniel J. Landsburg, MD¹, Richard T. Maziarz, MD², Amy Moskop, MD³, Leslie L. Popplewell, MD, MPH⁴, Scott R. Solomon, MD⁵, Michael T. Tees, MD, MPH⁶, Yongzi Yu, MS^7*, Aiesha Zia, MSc^8*, Stephen Lim, MD^9*, Avishek Pal, MSc^8*, Pei Hsu, MD^8* and Frederick Locke, MD¹⁰

¹Department of Medicine, University of Pennsylvania, Philadelphia, PA
²Knight Cancer Institute, Oregon Health and Science University, Portland, OR
³Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
⁴Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Atlanta, GA
⁵Northside Hospital Cancer Institute, Atlanta, GA
⁶Colorado Blood Cancer Institute, Denver, CO
⁷Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸Novartis Pharma AG, Basel, Switzerland
⁹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁰Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Lin Shen^1*, Jing Bao^2*, Lihong Shou^3*, Ying Lu^4*, Qi Zhu^5*, Li Wang, MD^6* and Weili Zhao⁶

¹Department of Hematology, Huadong Hospital Affiliated with Fudan University, Shanghai, China
²Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, China
³Department of Hematology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China
⁴Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
⁵Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁶Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Marzia Varettoni^1*, Emilia Cappello, MD^2*, Emanuela Boveri^3*, Virginia Valeria Ferretti^4*, Silvia Zibellini^1*, Gianmarco Favrin^2*, Chiara Varraso^1*, Marco Lucioni^3*, Cristina Picone^1*, Giulia Vittoria Facchetti^2*, Giovanni O. Palladini, MD, PhD^2,5, Marco Paulli, MD^3,6* and Luca Arcaini^1,2*

¹Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁴Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
⁵Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁶University of Pavia, Pavia, Italy

José Antonio Sánchez Salas, MD^1*, Estela Ruiz Ruiz, MD^2*, Almudena Cascales Hernandez, MD^2*, Joaquin Gomez Espuch, MD, PhD^3*, Andrea Poveda Garcia, MD^2*, Angela Heredia Cano, MD^2*, Miguel Blanquer Blanquer, MD, PhD⁴, Maria Carmen GARCIA Garay, MD^3*, Antonio Jose Martinez Mellado^2*, Alfredo Minguela Puras, PhD^5*, Agueda Bas Bernal, MD^6*, Vanessa Roldan Schilling, MD, PhD^2* and Antonio Salar Silvestre, MD, PhD^7*

¹Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), Guadix, Spain
²Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
³Hematology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
⁴Hematology, Hospital Clínico Universitario Virgen De La Arrixaca, Murcia, Spain
⁵Immunology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
⁶Pathology, Virgen de la Arrixaca University Hospital, Murcia (Spain), El Palmar, Murcia, Spain
⁷Hematology, Virgen de la Arrixaca University Hospital, Murcia (Spain), Murcia, Spain

Kriti Ahuja¹ and Arya Mariam Roy, MD^2,3

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Ohio State University/ The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
³Rosewell Park Cancer Center, Buffalo, NY

Ana Marin Niebla, MD PhD^1*, Mariana Bastos-Oreiro^2*, Amanda Isabel Perez, MD^3*, Alba Cabirta Touzón, MD^4*, Fatima De la Cruz Vicente, MD^5*, Marta Canelo^6*, Ana Jiménez Ubieto^7*, Sonia González De Villambrosia^8*, Ana Muntañola^9*, Hugo Daniel Luzardo Henríquez^10*, Eduardo Rios Herranz, MD^11*, Pilar Gómez^12*, Alberto López, MD^13*, Ana Saus Carreres^14*, Alejandro Martín García-Sancho^15*, Ana Garcia Noblejas^16*, Carlos Grande^17*, Pablo Prieto Martinez, MD^18*, Concepción Nicolás^19*, Antonio Gutierrez, MD, PhD^20*, Jose-Angel Hernandez Rivas, MD, PhD^21*, Blanca Sánchez González^22*, Rosalia Alonso Trillo, MD^23*, Eva Donato^24*, Paola Villafuerte Gutiérrez^25*, Daniel García Belmonte^26*, Silvia Rocio Verdesoto Cozzarelli^27*, Sandra Suarez Ordoñez, MD^28*, Emilia Pardal De La Mano^29*, Lucia Villalon Blanco^30*, Alicia Roldán-Pérez^31*, Eva Gine, MD³², Juan-Manuel Sancho, MD, PhD^33*, Raul Cordoba, MD, PhD³⁴, Beatriz De La Cruz^35*, Victor Navarro Garces, BSc^36* and Pau Abrisqueta, MD PhD³⁷

¹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
²Hematology Department, General University Hospital Gregorio Marañón, Madrid, Spain
³Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
⁴Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
⁵Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
⁶Hematology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
⁷Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁸Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
⁹Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
¹⁰Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹¹Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
¹²Hospital La Paz, Madrid, Spain
¹³Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁴Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
¹⁵Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain
¹⁶Hospital Universitario la Princesa, Madrid, ESP
¹⁷Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
¹⁸Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
¹⁹Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
²⁰Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain
²¹Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
²²Hematology Department, Hospital del Mar, Barcelona, Spain
²³Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
²⁴Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
²⁵Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
²⁶Hematology Department, Hospital Universitario La Zarzuela, Madrid, Spain
²⁷Hematololgy Department, Hospital de San Juan Despí Moisès Broggi, Barcelona, ESP
²⁸Hematology Department, Complejo Hospitalario de Vigo, Vigo, Spain
²⁹Hematology Department, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain
³⁰Hospital Universitario Fundación Alcorcón, Alcorc N, Madrid, ESP
³¹Hematology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
³²Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
³³ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
³⁴Hematology, University Hospital Fundación Jiménez Díaz, Madrid, Spain
³⁵Hematology Department, Hospital Universitario La Paz, Madrid, Spain
³⁶Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
³⁷Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Jorge J. Castillo, MD¹, Steven P. Treon, MD, PhD, FRCP², Catherine A. Flynn, NP^1*, Andres Ramirez-Gamero, MD^1*, Nina S Budano^1*, Alexandra N. Eurell^1*, Kirsten Meid, MPH^1* and Shayna R Sarosiek¹

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Inc., Boston, MA

Ingrid Glimelius, MD, PhD^1,2, Won Seog Kim^3*, Ewa Paszkiewicz-Kozik, MD, PhD^4*, Daniel Ernst, MD⁵, Reid W. Merryman, MD⁶, Claudia Moreira^7*, Sanfang Tu^8*, Yixin Ren^9*, Katherine Ryland, PhD⁹, Uzor C. Ogbu, MBBS, PhD⁹ and Pier Luigi Zinzani, MD, PhD^10,11

¹Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
²Akademiska sjukhuset-Blod-och tumorsjukdomar, Uppsala, Sweden
³Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Maria Sklodowska–Curie National Research Institute of Oncology, Warsaw, Poland
⁵Servicio de Hematología, Clínica Alemana de Santiago, Santiago, Chile
⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁷Instituto Português de Oncologia do Porto Francisco Gentil Epe, Porto, Portugal
⁸Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
⁹Merck & Co., Inc., Rahway, NJ
¹⁰IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
¹¹Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy

Jie Wang, MD, MS¹, Jihao Zhou, MD, PhD^2*, Yucai Wang, MD, PhD³, Javier L. Munoz, MD, MS, MBA⁴, Kevin G. Shim^3*, Muhamad Alhaj Moustafa, M.D., M.S.⁵, Firas Baidoun, MD⁶, Kaitlin Annunzio, DO⁷, Narendranath Epperla, MD MS⁷, Michael McLane, MD⁸, Yasmin H. Karimi, MD⁸, Binh Luu, BS^9*, Stephen E Spurgeon, MD⁹, Cheryl Chang, BA^10*, Zihan Wan, MS^11*, Diamone Gathers, MD^12*, Emily R. King, BA^13*, Marcus P. Watkins, PhD^14*, Nancy L. Bartlett, MD¹⁵, Christine E. Ryan, MD¹⁶, Genevieve M Gerhard, MD¹⁷, Philippe Armand, MD, PhD¹⁸, Ann S. LaCasce, MD¹⁹, Vedha Vaddaraju^20*, Danielle S Wallace, MD²¹, Vaishalee P Kenkre, MD²², Chase Junge, MD^22*, Natalie Grover, MD²³, Jorge A Florindez, MD²⁴, Reem Karmali, MD²⁵, Alexander V. Stanisic, MD^26*, Chen Zhang, MD, MS^27*, Parameswaran Venugopal, MD²⁷, Grace Ying, DO^28*, Caitlin Gribbin, MD, MS²⁹, Jia Ruan, MD, PhD³⁰, Navika D Shukla, MD³¹, Sonali M. Smith, MD³², Viktoriya Zelikson, MD³³, Michael E. Williams, MD ScM³³, Stefan K. Barta, MD³⁴, Omar Elghawy, MD^35*, Jake Schade, BA^36*, Rohini Navalekar, MPA^37*, Matthew Matasar, MD, MS³⁸, Andrew M Evens, DO MBA MSc³⁶, Alexey V. Danilov, MD, PhD³⁹ and Timothy S. Fenske, MD⁴⁰

¹Duke Cancer Institute, Hillsborough, NC
²Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic, Rochester, MN
⁴Mayo Clinic Arizona, Phoenix, AZ
⁵Division of Hematology, Mayo Clinic, Jacksonville, FL
⁶Mayo Clinic, Jacksonville, FL
⁷Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
⁸Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁰Duke University School of Medicine, Durham, NC
¹¹Duke Cancer Institute, Durham, NC
¹²Duke Cancer Institute, Durham
¹³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹⁴Division of Oncology, Washington University School of Medicine, St. Louis, MO
¹⁵Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO
¹⁶Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
¹⁷Beth Israel Deaconess Medical Center, Boston, MA
¹⁸Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA
¹⁹Dana-Farber Cancer Institute, Boston, MA
²⁰Wilmot Cancer Insititute, University of Rochester Medical Center, Rochester, NY
²¹Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
²²University of Wisconsin School of Medicine and Public Health, Madison, WI
²³University of North Carolina, Chapel Hill, NC
²⁴Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²⁵Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
²⁶Northwestern University Feinberg School of Medicine, Chicago, IL
²⁷Rush University Medical Center, Chicago, IL
²⁸Medical College of Wisconsin, Milwawkee, WI
²⁹Weill Cornell Medicine, New York, NY
³⁰Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
³¹Department of Medicine, University of Chicago, Chicago, IL
³²University of Chicago, Chicago, IL
³³University of Virginia Comprehensive Cancer Center, Charlottesville, VA
³⁴Abramson Cancer Center, The Fox Chase Cancer Center Foundation, Philadelphia, PA
³⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³⁶Rutgers Cancer Institute, New Brunswick, NJ
³⁷Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³⁸Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ
³⁹City of Hope National Medical Center, La Canada Flintridge, CA
⁴⁰Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI

Mazyar Shadman¹, Nancy L. Bartlett, MD², Matthew Matasar, MD, MS³, Stephen J. Schuster^4*, Sarit E. Assouline, MD⁵, Laurie H. H. Sehn, MD⁶, John Kuruvilla, MD, FRCPC⁷, Pratyush Giri, MBBS^8*, Chan Y. Cheah, MBBS DMSc⁹, Sascha Dietrich^10*, Keith Fay^11*, Matthew Ku, MBBS, PhD^12*, Loretta Nastoupil^13*, Michael C. Wei^14*, Shen Yin^14*, Connie Y. Ma^14*, Samuel Tracy^14*, Antonia Kwan^14*, Elicia Penuel^14* and L. Elizabeth Budde¹⁵

¹Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
²Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Jewish General Hospital, Montreal, QC, Canada
⁶BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Royal Adelaide Hospital, Adelaide, Australia
⁹Sir Charles Gairdner Hospital, Linear Clinical Research and the University of Western Australia, Perth, Australia
¹⁰Universitat Heidelberg, Heidelberg, Germany
¹¹St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
¹²St Vincent's Hospital, University of Melbourne, Melbourne, Australia
¹³MD Anderson Cancer Center, Houston, TX
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵City of Hope National Medical Center, Duarte, CA

Austin I. Kim, MD¹, Philippe Armand, MD, PhD², Christine E. Ryan, MD², Robert A. Redd, MS^3*, Megan Forsyth^2*, Juniper Mai^2*, Samantha Pazienza, BS^2*, Caitlin Bresnahan^2*, Vanessa M Kats^2*, Salah Abdulkarim^2*, Susan M Waisgerber, ANP^2*, Reid W. Merryman, MD², David C. Fisher, MD², Inhye E. Ahn, MD², Jennifer L. Crombie, MD², Oreofe O. Odejide, MD², Ann S. LaCasce, MD¹, Caron A. Jacobson, MD, MMSc², Eric D. Jacobsen, MD¹, Erin M. Parry, MD, PhD², David A. Qualls, MD², Amy C. Bessnow, MD, MPH^1*, Matthew S. Davids, MD, MMSc⁴, Jennifer R. Brown, MD, PhD², Jon E. Arnason, MD⁵, Michael Leukam, MD^5*, Peter A. Riedell, MD⁶ and Mark A. Murakami, MD²

¹Dana-Farber Cancer Institute, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
⁵Beth Israel Deaconess Medical Center, Boston, MA
⁶Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Christine E. Ryan, MD¹, Imran A. Nizamuddin, MD², Hari S. Raman, MD^3*, Robert A. Redd, MS^4*, Marcus P. Watkins, PhD^2*, Ann S. LaCasce, MD¹, David C. Fisher, MD³, Austin I. Kim, MD³, Matthew S. Davids, MD, MMSc³, Caron A. Jacobson, MD, MMSc³, Oreofe O. Odejide, MD³, Jennifer L. Crombie, MD³, Neha Mehta-Shah, MD², Amanda F. Cashen, MD², Armin Ghobadi, MD², Nancy L. Bartlett, MD², Eric D. Jacobsen, MD¹, Philippe Armand, MD, PhD³, Brad S. Kahl, MD⁵ and Reid W. Merryman, MD³

¹Dana-Farber Cancer Institute, Boston, MA
²Division of Oncology, Washington University School of Medicine, St. Louis, MO
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Washington University School of Medicine, Saint Louis, MO

Chan Y. Cheah, MBBS DMSc¹, Amanda Jane Johnston, MBBS, MD², Joel Wight, MBBS, FRACP, FRCPA, DMedSc^3*, Piers Blombery, MBBS⁴, Katharine L. Lewis⁵, Rory Bennett, MBChB^6*, Jing Xie, PhD^7*, Stella Vlahos^8*, Joyce Gonzales, MD^9*, Sally Binks^10* and John F. Seymour, MBBS, PhD⁶

¹Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²Westmead Hospital, Westmead, NSW, AUS
³Department of Haematology & Bone Marrow Transplantation, Townsville University Hospital, Townsville, Australia
⁴Peter Maccallum Cancer Centre, East Melbourne, VIC, Australia
⁵Sir Charles Gairdner Hospital, West Leederville, Australia
⁶Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁷Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁸Centre for Biostatistics and Clinical Trials, Melbourne, Australia
⁹Parkville Cancer Clinical Trials Unit, Peter MacCallum Cancer Centre, Victoria, Australia
¹⁰Sir Charles Gairdner Hospital, Perth, Australia

Elizabeth Brem, MD¹, Wojciech Jurczak, MD, PhD², David Belada³, Jaime Perez de Oteyza^4*, Aranzazu Alonso Alonso, MD^5*, Fevzi Altuntas, MD^6*, Michał Kwiatek^7*, Joshua Brody^8*, Ernesto Perez Persona^9*, Mustafa Yenerel^10*, Monica Tani^11*, Jingxian Cai^12*, Priya Deshpande^12*, Saleem Shariff^13*, Aafia Chaudhry¹², Hesham Mohamed¹², Srikanth Ambati¹², Ashish Risal^12* and Ruemu Birhiray¹⁴

¹University of California, Irvine, Orange, CA
²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
³University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
⁴Universidad CEU San Pablo, Madrid, Spain
⁵Hospital Universitario Quirónsalud Madrid, Madrid, Spain
⁶Ankara Oncology Training and Research Hospital, Ankara, Turkey
⁷Aidport Clinical Trials Hospital, Skorzewo, Poland
⁸Icahn School of Medicine at Mount Sinai, New York, NY
⁹Hospital Universitario de Navarra, Pamplona, Spain
¹⁰Istanbul University, Istanbul, Turkey
¹¹Santa Maria delle Croci Hospital, Ravenna, Italy
¹²Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹³Regeneron UK Ltd, Uxbridge, United Kingdom
¹⁴Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN

Judith Trotman, FRACP¹, Katherine Rankin, MBBS^2*, Ibrahim Tohidi-Esfahani, MBBS, FRACP, FRCPA¹, Alessandra Tedeschi, MD^3*, Constantine S. Tam, MD, MBBS⁴, Christian Buske, MD⁵, Roger G Owen, MD, MRCP, FRCPath^6*, Veronique LeBlond, MD^7*, Meletios A. Dimopoulos, MD⁸, Peter Smallwood^9*, Heather Allewelt, MD^10*, Wai Y Chan^10*, Radha Prathikanti, MPH, MBA^10*, Jingjing Schneider^10*, Remus Vezan, MD, PhD^10* and Stephen S. Opat, MBBS, FRACP, FRCPA¹¹

¹Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
²Calvary Mater Newcastle Hospital, Waratah, NSW, Australia
³ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
⁴Alfred Hospital and Monash University, Melbourne, VIC, Australia
⁵Institute of Experimental Cancer Research, Comprehensive Cancer Center Ulm, University Hospital Ulm, Ulm, Germany
⁶St. James’s University Hospital, Leeds, United Kingdom
⁷Sorbonne University, Pitié Salpêtrière Hospital, Paris, France
⁸National and Kapodistrian University of Athens, School of Medicine, Alexandra Hospital, Athens, Greece
⁹Patient author, Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
¹⁰BeiGene USA, Inc, San Mateo, CA
¹¹Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Lara Gallucci Figorelle, MD^1*, Renata Lyrio R Baptista, MD^2*, Flavia Dias Xavier, MD^3*, Peterson Tiago Galvao, MD^1*, Cristiane Milito^4*, Ruddy Dalfeor, MD^5*, Mariana Guarana, MD^6*, Katia Carneiro, PhD^7*, Bruna Souza Sabioni, MD^8*, Luana Brito^1*, Patricia Souza Marimon^9*, Sergio Augusto B Brasil, MD, PhD^10,11*, Celso Arrais-Rodrigues, MD, PhD¹², Verena Pfister^13,14*, Vitoria Siqueira^15*, Rafaella C. Samico^16*, Valeria Vianna, MSc^17* and Rony Schaffel, MD, PhD¹⁸

¹Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
²State University of Rio de Janeiro, Rio De Janeiro, Brazil
³Universidade Federal de Brasilia, BRASILA / DF - BRAZIL, BRA
⁴Hospital Universitario Clementino Fraga Filho, Petropolis, BRA
⁵Hospital Universitario Clementino Fraga Filho, Rio de Janeiro, Brazil
⁶Hospital de Clínicas Gafree e Guinle, Rio de Janeiro, Brazil
⁷Universidade Federal do Rio de Janeiro, Rio De Janeiro, BRA
⁸Estrada Teresopolis Itaipava, Teresopolis, BRA
⁹Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
¹⁰Hospital Santa Paula. São Paulo – Brazil, Sao Paulo, Brazil
¹¹Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
¹²Hospital Nove de Julho, DASA, São Paulo, Brazil
¹³Division of Hematology - UNIFESP, Sao Paulo, AC, Brazil
¹⁴Hospital 9 de Julho, São Paulo, Brazil
¹⁵Hospital Ophir Loyola, Belem, Brazil
¹⁶Hospital do Cancer de Muriaé, Muriaé, Minas Gerais, BRA
¹⁷Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio De Janeiro, AL, Brazil
¹⁸HUCFF / UFRJ, Rio de Janeiro, Brazil

David A Russler-Germain, MD, PhD¹, Fei Wan, PhD^2*, Emily R. King, BA^3*, Chaz Moreno^3*, Michelle Becker-Hapak^4*, Patrick Pence^4*, Joseph Rueve^4*, Sushanth A Pureti^4*, Dilan A. Patel, MD^3*, Brad S. Kahl, MD⁵, Neha Mehta-Shah, MD⁶, Todd A Fehniger⁷ and Nancy L. Bartlett, MD⁸

¹Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO
³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁴Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁵Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁶Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
⁷Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁸Siteman Cancer Center, Washington University Sch. of Med. Siteman Cancer Center, Saint Louis, MO

Vaishalee P Kenkre, MD¹, Yong Lin^2*, Narendranath Epperla, MD, MS^3,4, Saurabh A Rajguru, MD^5*, Julie E Chang, MD^6,7, Priyanka A. Pophali, MD⁸, Elyse I Harris, MD^9*, Christopher D Fletcher, MD^5*, Matthew Matasar, MD, MS¹⁰, Hussam Eltoukhy, MD¹¹, David A. Bond, MD, BS^12,13, Yazeed Sawalha, MD¹², Beth Christian, MD¹², Timothy Voorhees, MD, MSc¹², Mariah Endres^14*, Mitch Howard^14*, Damayanti Bhavsar^15*, Misty Fleming^16*, Jordan S. Carter, MD¹⁷ and Andrew M Evens, DO MBA MSc¹⁸

¹University of Wisconsin School of Medicine and Public Health, Madison, WI
²Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
³Ohio State University, Columbus, OH
⁴The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
⁵Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
⁶University of Wisconsin, Madison, WI
⁷Department of Medicine, University of Wisconsin, Madison, WI
⁸Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
⁹Carbone Cancer Center, University of Wisconsin–Madison, Madison, WI
¹⁰Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
¹¹Rutgers New Jersey Medical School, New Brunswick, NJ
¹²Division of Hematology, The Ohio State University, Columbus, OH
¹³The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
¹⁴University of Wisconsin Carbone Cancer Center, Madison, WI
¹⁵Rutgers, Cancer Institute of New Jersey, New Brunswick, NJ
¹⁶Ohio State University James Cancer Center, Columbus, OH
¹⁷Hospital of the University of Pennsylvania, Philadelphia, PA
¹⁸Rutgers Cancer Institute, New Brunswick, NJ

Luani Barge, MChD, FRACP, FRCPA^1,2,3*, Joshua W.D. Tobin, MD, PhD^1,3*, Niamh Waters, MBBS^4*, Ross Salvaris, MBBS^5*, Sam Lai, MBBS^6*, Tessa Potezny, MBBS^7*, Helen Cashman, MBBS^8*, Caitlyn Nguyen-Ngo, MBBS, PhD^9*, Denise Lee, MBBS^4,10*, Costas K. Yannakou, MBBS, PhD^11*, Nada Hamad, MBBS, MSc, BSc^8,12,13, Constantine S. Tam, MBBS, MD^7,14, Abir Bhattacharyya, MBBS⁶, Chan Y. Cheah, MBBS DMSc⁵, Kirk Morris, MBBS, FRACP, FRCPA², Eliza A. Hawkes, MD⁴ and Greg Hapgood, MD, PhD, FRACP, FRCPA^1,3*

¹Princess Alexandra Hospital, Brisbane, QLD, Australia
²Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia
³University of Queensland, Brisbane, QLD, Australia
⁴Austin Hospital, Melbourne, VIC, Australia
⁵Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
⁶Westmead Hospital, Sydney, NSW, Australia
⁷Alfred Hospital, Melbourne, VIC, Australia
⁸St Vincent's Hospital, Sydney, NSW, Australia
⁹Epworth HealthCare, Melbourne, VIC, Australia
¹⁰Boxhill Hospital, Melbourne, VIC, Australia
¹¹Molecular Oncology and Cancer Immunology, Epworth HealthCare, Melbourne, VIC, Australia
¹²The University of New South Wales, Kensington, NSW, Australia
¹³School of Medicine, University of Notre Dame, Sydney, Australia
¹⁴Monash University, Melbourne, VIC, Australia

Lu Zhang, MD^1*, Qinhua Liu^2*, Hui Zhou^3*, Huilai Zhang, MD⁴, Yujun Dong^5*, Xiaobo Wang^6*, Luqun Wang^7*, Liping Su⁸, Xiaojing Yan, MD, PhD⁹, Yan Li^10*, Mingzhi Zhang, MD¹¹, Kaiyang Ding^12*, Hui-Han Wang^13*, Hongling Peng, MD^14*, Liye Zhong, MD, PhD^15*, Lin Yang^16*, Lintao Bi, MD, PhD¹⁷, Da Gao, MD^18*, Guangxun Gao, MD^19*, Liang Huang²⁰, Chunyan Sun^21*, Jia Song, MD^22*, Wenbin Qian²³, Wenrong Huang²⁴, Zhenling Li^25*, Yao Liu^26* and Jian Li, MD¹

¹Department of Hematology, Peking Union Medical College Hospital, Beijing, China
²Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Hefei, China
³Hunan Cancer Hospital, Changsha, China
⁴Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
⁵Department of Hematology, Peking University First Hospital, Beijing, CHN
⁶The Second Hospital of Dalian Medical University, Dalian, China
⁷Qilu Hospital of Shandong University, Shandong, China
⁸Shanxi Province Cancer Hospital, Taiyuan, China
⁹Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China
¹⁰Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, CHN
¹¹The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
¹²Department of Hematology, The First Affiliated Hospital of USTC, Hefei, CHN
¹³Shengjing Hospital of China Medical University, Shenyang, CHN
¹⁴Department of hematology, The second xiangya hospital of Central South University, Changsha, China
¹⁵Guangdong Provinal People's Hospital, Guangzhou, China
¹⁶The Second Hospital of Hebe Medical University, Shijiazhuang, Hebei, China, Shijiazhuang, CHN
¹⁷Department of Hematology, China-Japan Union Hospital of Jilin University, Changchun, AL, China
¹⁸The affiliated hospital of inner mongolia medical univuniversity, Hohhot, China
¹⁹Department of Hematology, Xijing Hospital, Xi’An, China
²⁰Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²¹Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²²Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
²³Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²⁴Lymphoma & Plasma Cell Disease Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
²⁵China-Japan Friendship Hospital, Beijing, China
²⁶Chongqing University Cancer Hospital, Chongqing, China

Xin Li^1*, Jia Wei², Dong-feng Zeng^3*, Shu-nan Qi^4*, Bingzong Li, MD, PhD⁵, Wei Guo, MD/PhD^6*, Li Wang^7*, Yajun Li, MD^8*, Xudong Zhang, (M.D.)Dr.^9*, Yong Yang, MD^10*, Shukai Qiao^11*, Yan Zeng^3*, Yunfei Song^12*, Jing-wen Wang^1*, Jian-min Ma^1* and Liang Wang^13*

¹Beijing Tongren Hospital, Beijing, China
²Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech, Wuhan, Hubei, China
³Daping Hospital, Army Medical University, Chongqing, China
⁴National Cancer Center/ National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
⁵Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
⁶Department of Hematology, The First Hospital of Jilin University, Changchun, China
⁷Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁸Hunan Cancer Hospital, Changsha, China
⁹The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
¹⁰Fujian Medical University Union Hospital, Fuzhou, China
¹¹Hebei Medical University Second Hospital, Shijiazhuang, Hebei, China., Shijiazhuang, China
¹²Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
¹³Beijing Tongren Hospital, Guangzhou, China

Sarah Matarasso Greenfeld, MD^1*, Ian Shrier, MD, PhD, Dip Sport Med, FACSM^2* and Sarit E. Assouline, MD¹

¹Jewish General Hospital, McGill University, Montreal, QC, Canada
²Senior Investigator Emeritus, Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, QC, Canada

Kriti Ahuja¹ and Arya Mariam Roy, MD^2,3

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Ohio State University/ The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
³Rosewell Park Cancer Center, Buffalo, NY

Geoffrey Shouse, PhD, DO¹, Shin Yeu Ong, MD, FRCPath^2*, Max J Gordon, MD^3*, Tanya Siddiqi, MD⁴ and Alexey V. Danilov, MD, PhD⁵

¹City of Hope National Medical Center, Duarte, CA
²Singapore General Hospital, Singapore, Singapore
³Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Department of Hematology, City of Hope, Irvine, CA
⁵City of Hope National Medical Center, La Canada Flintridge, CA

Ana Marin Niebla, MD PhD^1*, Mariana Bastos-Oreiro^2*, Amanda Isabel Perez, MD^3*, Alba Cabirta Touzón, MD^4*, Fatima De la Cruz Vicente, MD^5*, Marta Canelo^6*, Ana Jiménez Ubieto^7*, Sonia González De Villambrosia^8*, Ana Muntañola^9,10*, Hugo Daniel Luzardo Henríquez^11*, Eduardo Rios Herranz, MD^12*, Beatriz De La Cruz^13*, Raul Cordoba, MD, PhD¹⁴, Ana Saus Carreres^15*, Alejandro Martín García-Sancho^16*, Ana Garcia Noblejas, MD, PhD^17*, Carlos Grande^18*, Pablo Prieto Martinez, MD^19*, Concepción Nicolás^20*, Antonio Gutierrez, MD, PhD^21*, Jose-Angel Hernandez Rivas, MD, PhD^22*, Blanca Sánchez-González^23*, Rosalia Alonso Trillo, MD^24*, Eva Donato^25*, Paola Villafuerte Gutiérrez^26*, Daniel García Belmonte^27*, Silvia Rocio Verdesoto Cozzarelli^28*, Sandra Suarez Ordoñez, MD^29*, Emilia Pardal De La Mano^30*, Lucia Villalon Blanco^31*, Eva Gine, MD³², Juan-Manuel Sancho, MD, PhD^33*, Alberto Lopez Garcia, MD³⁴, Alicia Roldán-Pérez^35*, Pilar Gómez^36*, Victor Navarro Garces, BSc^37* and Pau Abrisqueta, MD PhD³⁸

¹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
²Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
³Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
⁴Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
⁵Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
⁶Hematology Department, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
⁷Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
⁸Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
⁹MúTua Terrassa, Terrassa University Hospital, Terrassa, ESP
¹⁰Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
¹¹Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹²Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
¹³Hematology Department, Hospital Universitario La Paz, Madrid, Spain
¹⁴Hematology Department, Health Research Institute IIS-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
¹⁵Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
¹⁶Hematology Department, Salamanca University Hospital, IBSAL, CIBERONC, Salamanca, Spain
¹⁷Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
¹⁸Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
¹⁹Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
²⁰Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
²¹Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
²²Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
²³Hematology Department, Hospital del Mar, Barcelona, Spain
²⁴Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
²⁵Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
²⁶Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
²⁷Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
²⁸Hematololgy Department, Hospital de San Juan Despí Moisès Broggi, Barcelona, ESP
²⁹Hematology Department, Complejo Hospitalario de Vigo, Vigo, Spain
³⁰Hematology Department, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain
³¹Hospital Universitario Fundación Alcorcón, Alcorc N, Madrid, ESP
³²Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
³³Clinical Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain
³⁴Fundacion Jimenez Diaz University Hospital, Madrid, Spain
³⁵Hematology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
³⁶Hospital La Paz, Madrid, Spain
³⁷Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
³⁸Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain

Michael T. Tees, MD, MPH¹, David A. Bond, MD, BS², Nadia Khan, MD^3*, Farrukh T. Awan, MD⁴, Qiming Xu^5*, Hui Zhang^5*, Gladys Brown^5*, Jennifer A. Woyach, MD⁶ and Manish Patel, MD^7*

¹Colorado Blood Cancer Institute, a part of Sarah Cannon Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
²Division of Hematology, The Ohio State University, Columbus, OH
³Swedish Cancer Institute, Seattle, WA
⁴Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁵Accutar Biotechnology Inc., Cranbury
⁶Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
⁷Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL

Jose C. Villasboas Bisneto, MD¹, Pier Luigi Zinzani, MD, PhD², Andrew J. Davies, MD, PhD^3*, Robert Kridel, MD, PhD⁴, Guilherme Fleury Perini, MD⁵, Parth Rao, MD^6*, Joanna Mikita-Geoffroy^7*, Akshay Sudhindra, MD⁶ and Charalambos Andreadis, MD, MS^8*

¹Mayo Clinic, Rochester, MN
²Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
³Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
⁵Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
⁶Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Madison, NJ
⁷Bristol Myers Squibb, Boudry, Switzerland
⁸University of California, San Francisco, San Francisco, CA

Marie-Kristin Tilch, MD^1*, Christian Schmidt, MD^2*, Marek Trneny, Prof., MD, CSc.³, Eva Gine, MD⁴, Olivier Hermine, MD, PhD⁵, Anke Ohler^1*, Stephanie Herold^6*, Marta Illenyi^7*, Eva Hoster^8*, Christiane Pott, MD^9*, Martin Dreyling, MD¹⁰ and Georg Hess, MD^1*

¹Department of Hematology and Medical Oncology, University Medical School of the Johannes Gutenberg-University Mainz, Mainz, Germany
²Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
³First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
⁴Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
⁵CEREMAST Necker Hospital, Paris, France
⁶Department of Hematology and Medical Oncology, University Medical School of the Johannes Gutenberg-University Mainz, Mainz, AL, Germany
⁷LMU University Hospital, Munich, Germany, Department of Medicine III, Munich, Germany
⁸Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, DEU
⁹Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
¹⁰Department of Internal Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany